|
" Emerging Policy Issues in Synthetic Biology. "
| Document Type
|
:
|
BL
|
| Record Number
|
:
|
556202
|
| Doc. No
|
:
|
b384840
|
| Main Entry
|
:
|
OECD OCDE
|
| Title & Author
|
:
|
Emerging Policy Issues in Synthetic Biology.
|
| Publication Statement
|
:
|
OECD Publishing,, 2014.
|
| ISBN
|
:
|
1306934842
|
|
|
:
|
: 9264208429
|
|
|
:
|
: 9781306934848
|
|
|
:
|
: 9789264208421
|
| Contents
|
:
|
Foreword -- Abbreviations and acronyms -- Executive summary -- Synthetic biology: A new and promising technology -- The applications and potential benefits of synthetic biology -- Research infrastructure challenges for synthetic biology -- Changing investment patterns in synthetic biology -- Intellectual property issues and synthetic biology -- Governance, regulation and risk management in synthetic biology -- National policies for the development and application of synthetic biology.
|
| Abstract
|
:
|
Synthetic biology is at such an early stage of development that there is no uniform agreement as yet about what it actually is. To some, it represents a natural extension of genetic engineering, and therefore is "business as usual". For others, it is a way to bring mass manufacturing out from the decades of biotechnology research. Currently the discipline is limited by the ability to synthesise DNA cost-effectivelySynthetic biology is at such an early stage of development that there is no uniform agreement as yet about what it actually is. To some, it represents a natural extension of genetic engineering, and therefore is "business as usual". For others, it is a way to bring mass manufacturing out from the decades of biotechnology research. Currently the discipline is limited by the ability to synthesise DNA cost-effectivelySynthetic biology is at such an early stage of development that there is no uniform agreement as yet about what it actually is. To some, it represents a natural extension of genetic engineering, and therefore is "business as usual". For others, it is a way to bring mass manufacturing out from the decades of biotechnology research. Currently the discipline is limited by the ability to synthesise DNA cost-effectively",,,,,"Synthetic biology is at such an early stage of development that there is no uniform agreement as yet about what it actually is. To some, it represents a natural extension of genetic engineering, and therefore is "business as usual". For others, it is a way to bring mass manufacturing out from the decades of biotechnology research. Currently the discipline is limited by the ability to synthesise DNA cost-effectively but this is a technical barrier that it is anticipated will be overcome. Synthetic biology raises a number of policy issues around R & D funding, company investment, PPP arrangements and innovative financing, infrastructure requirements, education and training, intellectual property (IP), regulation, and public engagement. In preparation for the continuing development and greater use of synthetic biology, some countries have started to prepare synthetic biology technical roadmaps and a global roadmap for the medium term would be an extremely useful policy tool. Technical roadmaps could both identify likely future policy requirements, and be a useful vehicle in public engagement.
|
| Subject
|
:
|
Electronic books; Juvenile works; Juvenile literature
|
| |